Contrasting BIO-key International (BKYI) & Its Competitors

BIO-key International (NASDAQ:BKYI) is one of 953 publicly-traded companies in the “Software” industry, but how does it compare to its peers? We will compare BIO-key International to related businesses based on the strength of its risk, analyst recommendations, earnings, institutional ownership, valuation, profitability and dividends.

Analyst Ratings

This is a breakdown of recent ratings and price targets for BIO-key International and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1	1	0	0	1.50
BIO-key International Competitors	5717	21423	44694	1492	2.57

As a group, “Software” companies have a potential upside of 28.31%. Given BIO-key International’s peers stronger consensus rating and higher probable upside, analysts plainly believe BIO-key International has less favorable growth aspects than its peers.

Volatility and Risk

BIO-key International has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500. Comparatively, BIO-key International’s peers have a beta of 1.27, suggesting that their average stock price is 27% more volatile than the S&P 500.

Earnings and Valuation

This table compares BIO-key International and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
BIO-key International	$6.09 million	-$7.16 million	-0.60
BIO-key International Competitors	$1.90 billion	$385.94 million	110.48

BIO-key International’s peers have higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares BIO-key International and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BIO-key International	-50.01%	-67.31%	-40.28%
BIO-key International Competitors	-620.53%	20.98%	-8.95%

Insider & Institutional Ownership

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 42.0% of shares of all “Software” companies are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Comparatively, 19.8% of shares of all “Software” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

BIO-key International peers beat BIO-key International on 11 of the 12 factors compared.

BIO-key International Company Profile

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.